• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of cmajCMAJ Information for AuthorsCMAJ Home Page
CMAJ. Sep 28, 2004; 171(7): 721–723.
PMCID: PMC517851
The Cochrane Library

Antibiotics for sore throat to prevent rheumatic fever: Yes or No? How the Cochrane Library can help

With the winter season just around the corner you anticipate numerous patient enquiries and visits related to the use of antibiotics for the common cold and associated morbidities. One day a 45-year-old woman, a recent immigrant from India, presents to your office with sore throat and fever of 2 days' duration. In India her male cousin acquired rheumatic fever following a sore throat for which he did not receive antibiotics. She is now worried about getting rheumatic fever herself and insists on having antibiotics prescribed.

You decide to search the Cochrane Library (www.cochrane.org/reviews/clibintro.htm), to which your practice group subscribes, for evidence of the effectiveness of antibiotics for sore throat to prevent rheumatic fever. You log on and open Issue 3, 2004, and in the search box you enter the terms “(sore throat) and (antibiotics) and (rheumatic fever) and (primary care)” (Fig. 1). You find the review “Antibiotics for sore throat.”1 By printing the review, you obtain 41 pages of text with an abstract including “reviewers' conclusions.” (A lay summary of the review is available at Informed Health Online (www.informedhealthonline.org//item.aspx?tabid=8&review=000023), and that Web site has a direct link to the abstract of the review in the Cochrane Library.) After opening the review, you click on “outline” at the top of the tool bar, and the outline appears on the left of your screen. At the bottom left you click on “metaview graphs” and the outcome “Incidence of acute rheumatic fever within 2 months” is displayed as a forest plot. You notice that the authors have used an odds ratio (0.30, 95% confidence interval [CI] 0.20 to 0.45) as the default statistic for this outcome (Fig. 2). In the forest plot, no weights are assigned to the studies in which no outcomes in both the treatment and control groups occurred. Not being a gambler, you have a poor understanding of odds ratios. You are more familiar with the terms “relative risk,” “absolute risk difference” (“risk difference” as it is called in the Cochrane Library) and “number needed to treat” and you decide to use those statistics instead (Table 1). This is easily done. When you change the statistics in the “methods” box to relative risk, you find similar results as those for odds ratio (because the outcome of rheumatic fever is rare, the odds ratio and relative risk will be numerically close).

Table thumbnail
Table 1
figure 18FF2
Fig. 2: Forest plot of the outcome “Incidence of acute rheumatic fever within 2 months”1 with odds ratio as the statistic. Results are displayed as odds ratios (see the “Method box” to the left). The vertical line of 1 ...
figure 18FF1
Fig. 1: Opening page of the Cochrane Library, Issue 3, 2004. The screen will look like this after you enter your search terms and click on “The Cochrane Database of Systematic Reviews” and then “Complete reviews.” The review ...

In the methods section of the review you note that the reviewers made extensive efforts to identify eligible studies, and it would seem inappropriate to discard important information because there were no outcomes in both the treatment and control groups (indicating that there may be no advantage of the intervention under study). When you change the statistics to risk difference (–0.01, 95% CI –0.02 to –0.01), all of the studies are weighted (Fig. 3). A risk difference of 1% between the treatment and the control group of having the adverse outcome may convey a different message than an odds ratio of 0.30 would. By taking the inverse of the risk difference (in this case 1/0.01) you obtain the number needed to treat (100, 95% CI 50 to 100). It tells you that, on average, you need to treat 100 patients with sore throat with antibiotics to avoid 1 case of rheumatic fever. You note that the test for heterogeneity is statistically significant (p < 0.00001), which indicates that the effect size varies between studies, making the results less robust. In addition, you note that, in the studies conducted in the 1990s, there were no cases of rheumatic fever among 2484 patients enrolled. The reviewers performed a secondary analysis in which they separated studies published before and after 1975 and found no cases of rheumatic fever after 1975. As expected, there is no heterogeneity among the studies published after 1975, as there were no adverse outcomes in any group.

figure 18FF3
Fig. 3: Forest plot of the outcome “Incidence of acute rheumatic fever within 2 months”1 with risk difference as the statistic. Same comparison and outcome as in Fig. 2, but in the “Method box” the statistical test has ...

You summarize your findings in Table 2, and you have good evidence not to prescribe antibiotics for sore throat to prevent rheumatic fever in your patient. There may be subpopulations in Canada in whom the base rate of rheumatic fever is very high, as is the case in Australian Aborigines living in poor socioeconomic conditions, and therefore the use of antibiotics for sore throat is justified.

Table thumbnail
Table 2

Arne Ohlsson Kathie Clark

β See related article page 747

Supplementary Material

[The Cochrane Library - FREE 1 month trial registration]


Arne Ohlsson is Professor in the Departments of Paediatrics, Obstetrics and Gynaecology, and Health Policy Management and Evaluation, University of Toronto, Toronto, Ont., and the Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont. He is Director of the Canadian Cochrane Network and Centre. Kathie Clark is Co-director of the Canadian Cochrane Network and Centre, Faculty of Health Sciences, McMaster University, Hamilton, Ont.

For a trial use of the Cochrane Library, please refer to www.cmaj.ca for details.


1. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat [Cochrane review]. In: The Cochrane Library, Issue 3. Chichester (UK): John Wiley and Sons; 2004.

Articles from CMAJ : Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...